Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Revenue	$ 31,821	$ 30,662	$ 97,010	$ 90,162
Cost of products sold	30,093	28,973	92,089	85,285
Gross margin	1,728	1,689	4,921	4,877
Operating expenses:
Distribution, selling, general and administrative expenses	960	914	2,792	2,678
Restructuring and employee severance	15	6	31	19
Amortization and other acquisition-related costs	128	108	365	327
Impairments and loss on disposal of assets, net	2	0	15	17
Litigation (recoveries)/charges, net	18	5	37	(3)
Operating earnings	605	656	1,681	1,839
Other (income)/expense, net	(5)	0	(2)	5
Interest expense, net	46	44	134	134
Earnings before income taxes	564	612	1,549	1,700
Provision for income taxes	182	226	533	604
Net earnings	382	386	1,016	1,096
Net earnings attributable to noncontrolling interests	(1)	0	(2)	(1)
Net earnings attributable to Cardinal Health, Inc.	$ 381	$ 386	$ 1,014	$ 1,095
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 1.21	$ 1.18	$ 3.19	$ 3.33
Diluted (in shares)	$ 1.20	$ 1.17	$ 3.17	$ 3.30
Weighted-average number of common shares outstanding:
Basic (in shares)	316	328	318	328
Diluted (in shares)	318	331	320	331
Cash dividends declared per common share	$ 0.4489	$ 0.3870	$ 1.3467	$ 1.1610